Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Muga

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Medicina Clinica|May 22, 2018
The opioid crisisDaniel Fuster, Robert Muga
Medicina Clinica|March 12, 2020
Use of oipiods for chronic non-cancer pain. ReplyDaniel Fuster, Robert Muga
Medicina Clinica|January 13, 2024
[Substance use disorder: Epidemiology, medical consequences and treatment]Daniel Fuster, Paola Zuluaga, Robert Muga
Statistics in Medicine|September 28, 2004
A parametric survival model with an interval-censored covariateKlaus Langohr, Guadalupe Gómez, Robert Muga
Addiction Science & Clinical Practice|March 20, 2024
Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to actionLamia Y Haque, Paola Zuluaga, Robert Muga, et al.
Medicina Clinica|June 24, 2011
[Pathogenic interactions between alcohol and hepatitis C]Daniel Fuster, Jordi Tor, Celestino Rey-Joly, et al.
World Journal of Gastroenterology|June 24, 2021
Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol useDaniel Fuster, Xavier García-Calvo, Paola Zuluaga, et al.
World Journal of Hepatology|November 23, 2016
Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infectionsDaniel Fuster, Arantza Sanvisens, Ferran Bolao, et al.
Drug and Alcohol Dependence|August 30, 2017
Over-expression of CD8<sup>+</sup> T-cell activation is associated with decreased CD4<sup>+</sup> cells in patients seeking treatment of Alcohol Use DisorderPaola Zuluaga, Arantza Sanvisens, Eva Martínez-Cáceres, et al.
European Heart Journal|January 27, 2011
Acute coronary syndrome and cocaine use: 8-year prevalence and inhospital outcomesXavier Carrillo, Antoni Curós, Robert Muga, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Medicina Clinica|May 22, 2018
The opioid crisisDaniel Fuster, Robert Muga
Medicina Clinica|March 12, 2020
Use of oipiods for chronic non-cancer pain. ReplyDaniel Fuster, Robert Muga
Medicina Clinica|January 13, 2024
[Substance use disorder: Epidemiology, medical consequences and treatment]Daniel Fuster, Paola Zuluaga, Robert Muga
Statistics in Medicine|September 28, 2004
A parametric survival model with an interval-censored covariateKlaus Langohr, Guadalupe Gómez, Robert Muga
Addiction Science & Clinical Practice|March 20, 2024
Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to actionLamia Y Haque, Paola Zuluaga, Robert Muga, et al.
Medicina Clinica|June 24, 2011
[Pathogenic interactions between alcohol and hepatitis C]Daniel Fuster, Jordi Tor, Celestino Rey-Joly, et al.
World Journal of Gastroenterology|June 24, 2021
Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol useDaniel Fuster, Xavier García-Calvo, Paola Zuluaga, et al.
World Journal of Hepatology|November 23, 2016
Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infectionsDaniel Fuster, Arantza Sanvisens, Ferran Bolao, et al.
Drug and Alcohol Dependence|August 30, 2017
Over-expression of CD8<sup>+</sup> T-cell activation is associated with decreased CD4<sup>+</sup> cells in patients seeking treatment of Alcohol Use DisorderPaola Zuluaga, Arantza Sanvisens, Eva Martínez-Cáceres, et al.
European Heart Journal|January 27, 2011
Acute coronary syndrome and cocaine use: 8-year prevalence and inhospital outcomesXavier Carrillo, Antoni Curós, Robert Muga, et al.
Pageof 4